ABSTRACT

Throughout the past twenty years, the clinical use of biopharmaceutical product has markedly increased their obvious benefits over typical small-molecule drug products. These benefits embrace higher specificity, potency, targeting, and reduced adverse effects. Despite the substantial clinical and business success, the molecule structure and intrinsic instability of bio pharmaceuticals build their formulation and administration difficult and render parenteral delivery because the solely viable possibility in most cases. The utilization of nano carriers for economical delivery of biopharmaceuticals is important, to their sensible edges like protective from degradation during a hostile physiological setting, enhancing plasma half-life and retention time, facilitating absorption through the epithelial tissue, providing site-specific delivery. Within the current review, the use of nano carriers for intracellular delivery of biopharmaceuticals with endosomal escape and, in particular, the pathways of direct cytosolic delivery are approximately, means to insert a path between the caveolae, the release of the contact, in the middle membrane transfer, membrane interaction, direct transmission, and membrane disruption were discussed. Highly effective translation techniques were highlighted. Keywords: Biopharmaceuticals, Cytosolic delivery, Endosomal escape, Intracellular delivery, Nanocarriers
Publication date: 01/09/2022

https://ijbpas.com/pdf/2022/September/MS_IJBPAS_2022_6358.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.9.6358